ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-


cent for pigments. The company has been phasing out non- profitable items in order to remain competitive, ln order to rationalise operations the company sold its plant at Indore which manufactured chloroquine phosphate to BDH Pharma. This was mainly due to the decrease in off take of Guaiazulune in the international market. The company has decided to concentrate in future on drugs that are not in the ambit of price control.

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top